Kelly A. Romano, Director at Athira Pharma, Inc. (ATHA), bought 30,000 shares at $3.29 ($99K) on 2022-12-02, disclosed to the SEC on 2022-12-06.
Open-market purchase of $99k ATHA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |